SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-19-002014
Filing Date
2019-03-18
Accepted
2019-03-18 16:24:21
Documents
5
Period of Report
2019-05-03
Effectiveness Date
2019-03-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tnxp-def14a_051319.htm DEF 14A 877590
2 GRAPHIC tnxpdef14a051319001.jpg GRAPHIC 1047
3 GRAPHIC tnxpdef14a051319002.jpg GRAPHIC 5657
4 GRAPHIC tnxpdef14a051319003.jpg GRAPHIC 3654
5 GRAPHIC tnxpdef14a051319004.jpg GRAPHIC 7073
  Complete submission text file 0001387131-19-002014.txt   903321
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 19688533
SIC: 2834 Pharmaceutical Preparations